logo

For the Inventor, By the Inventor

Salt Lake City, UT, United States of America

Andreas Rohrwasser

This inventor holds 3 USPTO granted patents. Top assignee: University of Utah Research Foundation. Active years: 2001-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andreas Rohrwasser. Retrieved from https://idiyas.com/inventor/andreas-rohrwasser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

% Patents Active = 66.7

Average Co-Inventor Count = 2.6

ph-index = 1


Company Filing History:

goldMedal3 out of 1,687 
 
University of Utah Research Foundation
 patents

Years Active: 2001-2010

Loading Chart...
3 patents (USPTO):Explore Patents
1. 7749725 - Drug screening and diagnosis based on paracrine tubular renin-angiotensin system (2010-07-06),
2. 6495338 - Drug screening and diagnosis based on paracrine tubular renin-angiotensin system (2002-12-17),
3. 6177252 - Method to determine predisposition to hypertension (2001-01-23),

Title: Innovations of Andreas Rohrwasser

Introduction

Andreas Rohrwasser is a notable inventor based in Salt Lake City, UT (US). He has made significant contributions to the field of drug screening and diagnosis, particularly in relation to hypertension. With a total of 3 patents, his work has the potential to impact medical practices and improve patient outcomes.

Latest Patents

One of his latest patents focuses on drug screening and diagnosis based on the paracrine tubular renin-angiotensin system. This invention relates to a method for screening drugs intended for treating hypertension, utilizing the tubular renin-angiotensinogen system identified by Rohrwasser. Additionally, the invention provides a method to diagnose sodium status and sensitivity in individuals by measuring urinary angiotensinogen or angiotensin-I.

Career Highlights

Andreas Rohrwasser is affiliated with the University of Utah Research Foundation, where he continues to advance his research and innovations. His work is characterized by a commitment to improving healthcare through scientific discovery and innovation.

Collaborations

Rohrwasser has collaborated with esteemed colleagues such as Jean-Marc Lalouel and Terry Morgan. These partnerships have further enriched his research endeavors and contributed to the development of his patented technologies.

Conclusion

Andreas Rohrwasser's contributions to drug screening and diagnosis highlight his role as an influential inventor in the medical field. His innovative approaches have the potential to enhance treatment options for hypertension and improve diagnostic methods for sodium sensitivity.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…